HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Honore Selected Research

Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)

11/2006Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Honore Research Topics

Disease

10Pain (Aches)
01/2008 - 01/2000
5Neuralgia (Stump Neuralgia)
06/2009 - 01/2000
5Neoplasms (Cancer)
05/2001 - 01/2000
3Bone Neoplasms (Bone Cancer)
05/2001 - 05/2000
2Hyperalgesia
11/2006 - 09/2006
2Cancer Pain
05/2000 - 01/2000
1Zoonoses
03/2018
1Morbid Obesity
10/2009
1Liver Diseases (Liver Disease)
10/2009
1Postoperative Pain
06/2009
1Heart Arrest (Cardiac Arrest)
06/2007
1Hypersensitivity (Allergy)
12/2006
1Arthralgia (Joint Pain)
11/2006
1Acute Pain
09/2006
1Sarcoma (Soft Tissue Sarcoma)
05/2001
1Lactic Acidosis
03/2000
1Pancreatitis
03/2000
1Hypertrophy
01/2000

Drug/Important Bio-Agent (IBA)

6Analgesics (Analgesic Drugs)IBA
06/2009 - 12/2000
3CannabinoidsIBA
06/2009 - 01/2008
3Freund's AdjuvantIBA
11/2006 - 01/2000
3OsteoprotegerinIBA
05/2001 - 05/2000
2Capsaicin (Zostrix)FDA Link
12/2006 - 09/2006
1Cannabinoid Receptor AgonistsIBA
06/2009
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
06/2009
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2008
1CB2 Cannabinoid ReceptorIBA
01/2008
1(1- (2- morpholin- 4- yl- ethyl)- 1H- indol- 3- yl)- (2,2,3,3- tetramethylcyclopropyl)methanoneIBA
01/2008
1Formaldehyde (Formol)FDA Link
06/2007
1Purinergic P2X7 ReceptorsIBA
06/2007
1Purinergic P2 Receptors (ADP Receptor)IBA
06/2007
13- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA
06/2007
1Gabapentin (Neurontin)FDA LinkGeneric
12/2006
1Lamotrigine (Lamictal)FDA LinkGeneric
12/2006
1Morphine (MS Contin)FDA LinkGeneric
12/2006
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
11/2006
1metabotropic glutamate receptor type 1IBA
11/2006
1A-841720IBA
11/2006
1CationsIBA
09/2006
1LipidsIBA
09/2006
1PyrrolidinesIBA
09/2006
1TRPV Cation ChannelsIBA
09/2006
1N- 1H- indazol- 4- yl- N'- (5- piperidin- 1- yl- 2,3- dihydro- 1H- inden- 1- yl)ureaIBA
09/2006
11- (3- (trifluoromethyl)pyridin- 2- yl)- N- (4- (trifluoromethylsulfonyl)phenyl)- 1,2,3,6- tetrahydropyridine- 4- carboxamideIBA
09/2006
1Urea (Carbamide)FDA LinkGeneric
09/2006
1LigandsIBA
09/2006
1Dental AmalgamIBA
05/2001
1GalaninIBA
01/2000
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2000
1Calcitonin Gene-Related PeptideIBA
01/2000
1Substance PIBA
01/2000
1Dynorphins (Dynorphin)IBA
01/2000
1Neuropeptide YIBA
01/2000
1protein kinase C gamma (PRKCG)IBA
01/2000

Therapy/Procedure

5Therapeutics
03/2018 - 03/2000
2Ligation
11/2006 - 01/2000
1Liver Transplantation
10/2009
1Contraindications
10/2009
1Intraperitoneal Injections
11/2006
1Oral Administration
09/2006
1Chemoradiotherapy
09/2000